mHealth Solutions for Perinatal Mental Health: Scoping Review and Appraisal Following the mHealth Index and Navigation Database Framework.

MIND digital mental health mobile phone perinatal mental health pregnancy

Journal

JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439

Informations de publication

Date de publication:
17 01 2022
Historique:
received: 26 05 2021
accepted: 19 11 2021
revised: 06 09 2021
entrez: 17 1 2022
pubmed: 18 1 2022
medline: 2 2 2022
Statut: epublish

Résumé

The ever-increasing pressure on health care systems has resulted in the underrecognition of perinatal mental disorders. Digital mental health tools such as apps could provide an option for accessible perinatal mental health screening and assessment. However, there is a lack of information regarding the availability and features of perinatal app options. This study aims to evaluate the current state of diagnostic and screening apps for perinatal mental health available on the Google Play Store (Android) and Apple App Store (iOS) and to review their features following the mHealth Index and Navigation Database framework. Following a scoping review approach, the Apple App Store and Google Play Store were systematically searched to identify perinatal mental health assessment apps. A total of 14 apps that met the inclusion criteria were downloaded and reviewed in a standardized manner using the mHealth Index and Navigation Database framework. The framework comprised 107 questions, allowing for a comprehensive assessment of app origin, functionality, engagement features, security, and clinical use. Most apps were developed by for-profit companies (n=10), followed by private individuals (n=2) and trusted health care companies (n=2). Out of the 14 apps, 3 were available only on Android devices, 4 were available only on iOS devices, and 7 were available on both platforms. Approximately one-third of the apps (n=5) had been updated within the last 180 days. A total of 12 apps offered the Edinburgh Postnatal Depression Scale in its original version or in rephrased versions. Engagement, input, and output features included reminder notifications, connections to therapists, and free writing features. A total of 6 apps offered psychoeducational information and references. Privacy policies were available for 11 of the 14 apps, with a median Flesch-Kincaid reading grade level of 12.3. One app claimed to be compliant with the Health Insurance Portability and Accountability Act standards and 2 apps claimed to be compliant with General Data Protection Regulation. Of the apps that could be accessed in full (n=10), all appeared to fulfill the claims stated in their description. Only 1 app referenced a relevant peer-reviewed study. All the apps provided a warning for use, highlighting that the mental health assessment result should not be interpreted as a diagnosis or as a substitute for medical care. Only 3 apps allowed users to export or email their mental health test results. These results indicate that there are opportunities to improve perinatal mental health assessment apps. To this end, we recommend focusing on the development and validation of more comprehensive assessment tools, ensuring data protection and safety features are adequate for the intended app use, and improving data sharing features between users and health care professionals for timely support.

Sections du résumé

BACKGROUND
The ever-increasing pressure on health care systems has resulted in the underrecognition of perinatal mental disorders. Digital mental health tools such as apps could provide an option for accessible perinatal mental health screening and assessment. However, there is a lack of information regarding the availability and features of perinatal app options.
OBJECTIVE
This study aims to evaluate the current state of diagnostic and screening apps for perinatal mental health available on the Google Play Store (Android) and Apple App Store (iOS) and to review their features following the mHealth Index and Navigation Database framework.
METHODS
Following a scoping review approach, the Apple App Store and Google Play Store were systematically searched to identify perinatal mental health assessment apps. A total of 14 apps that met the inclusion criteria were downloaded and reviewed in a standardized manner using the mHealth Index and Navigation Database framework. The framework comprised 107 questions, allowing for a comprehensive assessment of app origin, functionality, engagement features, security, and clinical use.
RESULTS
Most apps were developed by for-profit companies (n=10), followed by private individuals (n=2) and trusted health care companies (n=2). Out of the 14 apps, 3 were available only on Android devices, 4 were available only on iOS devices, and 7 were available on both platforms. Approximately one-third of the apps (n=5) had been updated within the last 180 days. A total of 12 apps offered the Edinburgh Postnatal Depression Scale in its original version or in rephrased versions. Engagement, input, and output features included reminder notifications, connections to therapists, and free writing features. A total of 6 apps offered psychoeducational information and references. Privacy policies were available for 11 of the 14 apps, with a median Flesch-Kincaid reading grade level of 12.3. One app claimed to be compliant with the Health Insurance Portability and Accountability Act standards and 2 apps claimed to be compliant with General Data Protection Regulation. Of the apps that could be accessed in full (n=10), all appeared to fulfill the claims stated in their description. Only 1 app referenced a relevant peer-reviewed study. All the apps provided a warning for use, highlighting that the mental health assessment result should not be interpreted as a diagnosis or as a substitute for medical care. Only 3 apps allowed users to export or email their mental health test results.
CONCLUSIONS
These results indicate that there are opportunities to improve perinatal mental health assessment apps. To this end, we recommend focusing on the development and validation of more comprehensive assessment tools, ensuring data protection and safety features are adequate for the intended app use, and improving data sharing features between users and health care professionals for timely support.

Identifiants

pubmed: 35037894
pii: v10i1e30724
doi: 10.2196/30724
pmc: PMC8804959
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e30724

Informations de copyright

©Benedetta Spadaro, Nayra A Martin-Key, Erin Funnell, Sabine Bahn. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org), 17.01.2022.

Références

Lancet. 2014 Nov 15;384(9956):1789-99
pubmed: 25455249
Stud Health Technol Inform. 2015;210:175-9
pubmed: 25991125
BMC Psychiatry. 2021 Apr 20;21(1):200
pubmed: 33879130
Midwifery. 2018 Apr;59:47-58
pubmed: 29353691
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
J Psychiatr Res. 2018 Sep;104:100-107
pubmed: 30015264
JMIR Ment Health. 2018 Nov 23;5(4):e10652
pubmed: 30470681
Fam Pract. 2017 Feb;34(1):11-19
pubmed: 27660558
Adv Nutr. 2019 Sep 1;10(5):816-826
pubmed: 31079143
Midwifery. 2019 Jul;74:126-133
pubmed: 30953968
J Med Internet Res. 2021 Jun 4;23(6):e27132
pubmed: 34033582
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
PLoS One. 2017 Jul 12;12(7):e0180867
pubmed: 28704442
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
NPJ Digit Med. 2020 Jul 30;3:100
pubmed: 32821855
Lancet Digit Health. 2019 Jun;1(2):e52-e54
pubmed: 33323229
BJPsych Open. 2019 Jan;5(1):e5
pubmed: 30762504
Int Rev Psychiatry. 2019 May;31(3):210-228
pubmed: 30701995
Psychol Med. 2014 Apr;44(5):927-36
pubmed: 23822932
Syst Rev. 2019 Jan 19;8(1):27
pubmed: 30660183
Am J Psychiatry. 2016 Feb 1;173(2):117-27
pubmed: 26514657
Matern Child Health J. 2021 Mar;25(3):349-352
pubmed: 33543374
Psychiatr Serv. 2020 Nov 1;71(11):1114-1119
pubmed: 32664822
JMIR Ment Health. 2017 Oct 20;4(4):e42
pubmed: 29054833
Int J Gynaecol Obstet. 2020 Jul;150(1):31-33
pubmed: 32524596
Am J Obstet Gynecol. 2021 Jun;224(6):628-629
pubmed: 33705747
Arch Womens Ment Health. 2016 Oct;19(5):927-35
pubmed: 27296356
Arch Womens Ment Health. 2021 Dec;24(6):881-892
pubmed: 33929636
BMC Med. 2017 Aug 9;15(1):150
pubmed: 28789659
Am J Public Health. 2020 Jun;110(6):888-896
pubmed: 32298167
J Psychosom Res. 2014 Sep;77(3):242-3
pubmed: 25149035
BMJ. 2020 Nov 11;371:m4022
pubmed: 33177069
J Affect Disord. 2020 Dec 1;277:5-13
pubmed: 32777604
Cyberpsychol Behav Soc Netw. 2016 Jun;19(6):412-5
pubmed: 27327069
J Med Internet Res. 2020 Apr 13;22(4):e17011
pubmed: 32281939
Mhealth. 2018 Mar 23;4:6
pubmed: 29682510
J Psychosom Res. 2007 Sep;63(3):297-303
pubmed: 17719368
J Psychosom Res. 2014 Jun;76(6):489-91
pubmed: 24840147
Sleep. 2011 May 01;34(5):601-8
pubmed: 21532953
N C Med J. 2020 Jan-Feb;81(1):45-50
pubmed: 31908334
BJOG. 2009 Jul;116(8):1019-27
pubmed: 19438499
Lancet Psychiatry. 2018 Oct;5(10):845-854
pubmed: 30170964
Br J Psychiatry. 1987 Jun;150:782-6
pubmed: 3651732
J Clin Psychiatry. 2019 Jul 23;80(4):
pubmed: 31347796
J Appl Psychol. 1948 Jun;32(3):221-33
pubmed: 18867058
Lancet Psychiatry. 2019 Sep;6(9):786-792
pubmed: 30981755
Sleep Med. 2001 Jul;2(4):297-307
pubmed: 11438246
Birth. 2010 Jun;37(2):106-15
pubmed: 20557533
JMIR Ment Health. 2020 Mar 26;7(3):e18848
pubmed: 32213476
BMJ Open. 2019 Jan 24;9(1):e024803
pubmed: 30679296
J Affect Disord. 2009 Apr;114(1-3):163-73
pubmed: 18752852
Fam Pract. 2011 Apr;28(2):172-87
pubmed: 20978241
Int J Gynaecol Obstet. 2020 Jun;149(3):273-286
pubmed: 32248521
J Psychiatr Res. 2018 Sep;104:235-248
pubmed: 30114665
Health Informatics J. 2020 Dec;26(4):2930-2945
pubmed: 32914696
Am J Prev Med. 2016 Dec;51(6):1051-1059
pubmed: 27659122
BMJ Open. 2021 Mar 19;11(3):e047001
pubmed: 33741674
JMIR Mhealth Uhealth. 2016 Feb 10;4(1):e15
pubmed: 26863986
J Affect Disord. 2019 Apr 15;249:96-103
pubmed: 30769297

Auteurs

Benedetta Spadaro (B)

Cambridge Centre for Neuropsychiatric Research, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.

Nayra A Martin-Key (NA)

Cambridge Centre for Neuropsychiatric Research, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.

Erin Funnell (E)

Cambridge Centre for Neuropsychiatric Research, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.

Sabine Bahn (S)

Cambridge Centre for Neuropsychiatric Research, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.
Psyomics Ltd, Cambridge, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH